ReviewAnnals of hematology2024

Role of brentuximab vedotin plus sirolimus in the treatment of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder: a case-based review.

Kuangguo Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.